Polypharmacy and deprescribing

Polypharmacy is a common issue in clinical practice, with 20% of adults given ≥5 regular medications. It particularly impacts elderly individuals and those with multiple morbidities, and is worsened by single-disease, guideline-driven prescribing and service pressures. Although sometimes appropriate, it can also be problematic, associated with a range of adverse outcomes in cluding hazardous prescribing, excess treatment burden, poor quality of life, higher health service use, and increased morbidity and mortality.
Source: Medicine - Category: Internal Medicine Authors: Tags: Clinical pharmacology Source Type: research